inSili.com GmbH
Source of intellectual property and unique expertise for pharmaceutical and biotechnological R&D
Through a first class service, inSili.com provides know-how and world-leading technology for virtual screening of pioneering de novo designed molecular agents.
inSili.com's industry-proven design concept is built on groundbreaking algorithms like CATS (Chemically Advanced Template Search) and DOGS (Design Of Genuine Structures) for the discovery of new molecular entities with desirable properties and selected macromolecular target profiles.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
No news
No milestones
No Jobs
No videos and documents
ETH Spin-off
http://www.vpf.ethz.ch/transfer/firmgruend/spinoff_list/by_years/2009
inSili.com GmbH
Source of intellectual property and unique expertise for pharmaceutical and biotechnological R&D
Website:
insili.com
Headquarter:
Zürich
Foundation Date:
April 2013
Technology:
- Biotech
Sectors:
- Screening